Preliminary clinical studies have also demonstrated that there are subsets of lupus patients with an estrogen-exacerbated disease and one proposed hypothesis is that selective estrogen receptor modulators such as Tamoxifen may have therapeutic potential in SLE patient management [26,27]. This evidence concerns the gene ESR1 and systemic lupus erythematosus.